<DOC>
	<DOCNO>NCT00593112</DOCNO>
	<brief_summary>This open label study use daily 126mg/day Concerta treatment child adolescent , age 12-17 , meet DSM-IV criterion ADHD . Specific hypotheses follow : Hypothesis 1 : Children adolescent ADHD significantly high ACC DLPFC Glutamate/myo-Inositol contain compound ( Glu/Ino ) Glutamate/creatine + phosphocreatine ( Glu/Cr ) match HCS . Hypothesis 2 : After six week treatment , OROS methylphenidate low ACC DLPFC Glu/Ino Glu/Cr level child ADHD methylphenidate responder .</brief_summary>
	<brief_title>Proton Magnetic Spectroscopy Children Adolescents With ADHD Before After Treatment With OROS Methylphenidate</brief_title>
	<detailed_description>The primary objective study use 1H MRS ass Glutamate ( Glu ) , myo-Inositol ( Ino ) , creatine + phosphocreatine ( Cr ) level brain region interest 20 child ADHD age 12-17 year old , six-week open treatment trial OROS methylphenidate . For comparison , 1H MRS also obtain 20 control match age gender . We also scan 20 child ADHD age 12-17 year old currently enrol protocol entitle `` Prevention Cigarette Smoking ADHD Youth Concerta '' ( 2003-P-001313 ) stable dose Concerta . These 20 child scan medication medication</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1 . Male female subject , 1217 year age . 2 . ADHD subject must meet study criterion `` Prevention Cigarette Smoking ADHD Youth CONCERTA Protocol '' ; # 2003P001313 . 3 . Control subject must meet full DSMIV criterion Attention Deficit Hyperactivity Disorder , current major psychiatric disorder . 4 . Each subject his/her authorized legal representative must understand nature propose study , must sign informed consent inform assent document . 5 . Subject parent must level understanding sufficient communicate intelligently investigator study coordinator , cooperate study procedure . 1 . Clinically significant chronic medical condition include hepatic , renal , gastroenterologic , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic , hematologic disease . 2 . Organic brain disorder mental retardation ( I.Q . &lt; 75 ) . 3 . Contraindication MRI include presence metal surgical device ( plate , implant , brace item ) . 4 . Pregnancy ; woman child bear potential must use medically approve method birth control . Women child bear potential receive urinary pregnancy test prior MR scan session . 5 . Severe phobia small , enclosed space . 6 . Investigator his/her immediate family ; define investigator 's spouse , parent , child , grandparent , grandchild eligible participate treatment arm study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>HMRS Scanning</keyword>
	<keyword>ADHD</keyword>
	<keyword>Child</keyword>
	<keyword>Adolescent</keyword>
	<keyword>HMRS Scans</keyword>
</DOC>